| Open Document File Size: 817,51 KBShare Result on Facebook
City San Antonio / Delhi / / Company Foerster LLP / tion Cos. / CVS / Mor / Wyeth / Walgreen Co. / Robert Coopman Consultants / / Continent South America / / Country Venezuela / Russia / United States / Trinidad / China / Ghana / India / / Currency USD / / / Event Product Issues / Product Recall / FDA Phase / Legal Issues / / IndustryTerm failure-to-warn law / pharmaceutical prod / tate-law design defect / state law / generics manufacturers with another tool / counterfeit products / dosage serve state common-law liabil / manufacturing cost / gy products / counter products / sign-defect law / food retailer / generic manufacturers with another tool / federal law / oncology manufacturing / state-law obligations / law / suitcase traders / / Organization Food and Drug Administration / House of Representatives / Supreme Court / Senate / Congress / UN Court / US Federal Reserve / FDA / / Person Robert Coopman / Alito / James Huston / Kennedy / Breyer / Joanna Simon Parallel / Joanna Simon / Scalia / Erin Bosman / Thomas / Karen Bartlett / Julie Park / / Position Chief Justice / mayor / Solicitor General / actor / wholesaler / General / writer / president of Robert Coopman / president / / Product drug / Stevens-Johnson syndrome/ cule drug / / ProvinceOrState Assam / New Hampshire / / Region Middle East / Caribbean / /
SocialTag |
Pg1Pg1 PERSPECTIVES: PHARMACY 2013 CHAIN DRUG REVIEW A victory for generics suppliers By James Huston, Erin Bosman,